Overview

* Colgate-Palmolive ( CL ) Q3 net sales rise 2%, beating analyst expectations

* Adjusted EPS for Q3 beats analyst estimates

* Company exits non-strategic private label pet sales, impacting organic sales growth

Outlook

* Company expects full-year 2025 organic sales growth of 1% to 2%

* Colgate-Palmolive ( CL ) sees full-year net sales up low single digits

* Company expects full-year gross profit margin to align with 60.1%

* 2030 strategy and Strategic Growth and Productivity Program are positioned to drive growth

Result Drivers

* CATEGORY SLOWDOWN - Despite slowing category growth in many markets, Colgate-Palmolive ( CL ) achieved net and organic sales growth

* EXIT FROM PET SALES - Organic sales were negatively impacted by the exit from non-strategic private label pet sales

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Meet $5.13 $5.13

bln bln (12

Analysts

)

Q3 Beat $0.91 $0.89

Adjusted (15

EPS Analysts

)

Q3 EPS $0.91

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 9 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the personal products peer group is "buy"

* Wall Street's median 12-month price target for Colgate-Palmolive Co ( CL ) is $90.00, about 15% above its October 30 closing price of $76.51

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 24 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)